pHisoHex, brand of hexachlorophene detergent cleanser, is an antibacterial sudsing emulsion for topical administration.
pHisoHex is indicated for use as a surgical scrub and a bacteriostatic skin cleanser. It may also be used to control an outbreak of gram-positive infection where other infection control procedures have been unsuccessful. Use only as long as necessary for infection control (see PRECAUTIONS: Information for Patients).
Clinical Trials Related to Phisohex (Hexachlorophene Topical)
A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections [Completed]
This clinical trial tests the hypothesis that body decolonization of patients with recurrent
community-associated (CA) MRSA infections will significantly reduce the likelihood of
recurrent CA-MRSA infection.
Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons [Active, not recruiting]
This study will prospectively evaluate the prevalence and incidence (over a two year period)
of MRSA colonization and infection among HIV-infected military beneficiaries to determine
predictors for the development of MRSA colonization and infection. This study will also
investigate the utility of decolonization procedures for clearance of MRSA carriage and
prevention of MRSA infections. Finally, the molecular characteristics and the antimicrobial
sensitivities of isolates in this population will be determined.
Community-Acquired Methicillin Resistant Staphylococcus Aureus Colonization in Pregnant Women and Infections in Newborns [Recruiting]
Community acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is an emerging
pathogen of the 21st century whose incidence as a cause of local and invasive infections has
significantly increased, especially in previously healthy term and near term newborns. The
etiology of the increasing incidence of infection in previously healthy term and near-term
newborns remains unclear.
1. The incidence of previously healthy newborns infected with CA-MRSA skin & soft tissue
(SSTI) and invasive infections is higher in those born to mothers colonized with
2. Pregnant women colonized with CA-MRSA are at higher risk for post-partum infection with
1. To determine the incidence of nasal and vaginal colonization with CA-MRSA in pregnant
women and determine the genetic similarities of these strains.
2. To study CA-MRSA transmission dynamics and evaluate the incidence of SSTI and invasive
infections in newborns born to S. aureus colonized mothers.
3. To study the efficacy of attempted decolonization in CA-MRSA colonized mothers in
decreasing the incidence of transmission and development of SSTI and invasive
infections in their infants during the first month of life.
Understanding the epidemiology of the transmission dynamics of CA-MRSA in previously healthy
newborns will provide important information to support the development of strategies aimed
at the interruption of transmission and prevention of infection caused by CA-MRSA in
newborns, as well as in pregnant women. This will also allow for the development of
infection control strategies to prevent the spread of this organism among post-partum units
Page last updated: 2012-11-21